CVR 43630938Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)TaastrupFounded 1 Nov 2022
Employees
2
CVR registry, May 2026
-1 (-33.3%) over 12 months
Gross profit
636.6K
DKK, annual report 2025
-25.3% on 2024
Result
-41.5K
DKK, annual report 2025
Equity
-32.3K
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Tailwind Biotech ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexCTW Holding ApSCVR 43573756, 25% to under 33.3% of capital and votes, since 1 Nov 2022
LCAR Holding ApSCVR 43573780, 25% to under 33.3% of capital and votes, since 1 Nov 2022
and 2 moreChristopher Thomas Workmansince 1 Nov 2022
Lorenzo Carvellisince 1 Nov 2022
Mirko Cerianisince 1 Nov 2022
Equity was negative at 31 Dec 2025: -32.3K DKK. Dandex estimate, computed 24 Oct 2026.
CVR 3733430810% to under 15% of capital and votessince 1 Nov 2022
CVR 4357375625% to under 33.3% of capital and votessince 1 Nov 2022
CVR 4357378025% to under 33.3% of capital and votessince 1 Nov 2022
CVR 4357539225% to under 33.3% of capital and votessince 1 Nov 2022
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 4357376420% to under 25% of capital and votes1 Nov 2022 to 13 Oct 2023
CVR records founders at incorporation. It does not record whether they are alive or still involved.
1 Nov 2022 to 24 Oct 2026.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Gross profit | 322 | 853 | 637 |
| Operating profit | Not reported | -45 | -60 |
| Result for the year | -4 | -27 | -42 |
| Equity | 36 | 9 | -32 |
| Total assets | 68 | 49 | 24 |
| Employees (average) | 1 | 3 | 0 |
| Credit metrics (Dandex calculations) | |||
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | Not reportednote 2 | -25.3% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | Not reportednote 3 | -28note 4 | 23 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2023 covers 14 months (1 Nov 2022 to 31 Dec 2023). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Tailwind Biotech ApS has moved to a new address, with a potential need for new suppliers.
Signal, a Dandex estimate. Lapses 29 Oct 2026.
Tailwind Biotech ApS has moved to a new address, with a potential need for new suppliers.
Signal, a Dandex estimate. Lapses 1 Dec 2026.
1 registered in CVR.
P-number 1028731627Blåkildevej 9, 2630 Taastrup
